499 related articles for article (PubMed ID: 27702851)
1. The wearable cardioverter-defibrillator: current technology and evolving indications.
Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I
Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851
[TBL] [Abstract][Full Text] [Related]
2. Wearable cardioverter-defibrillators: A review of evidence and indications.
Cheung CC; Olgin JE; Lee BK
Trends Cardiovasc Med; 2021 Apr; 31(3):196-201. PubMed ID: 32205034
[TBL] [Abstract][Full Text] [Related]
3. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China.
Jiang X; Ming WK; You JHS
J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2387-2396. PubMed ID: 31502350
[TBL] [Abstract][Full Text] [Related]
4. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
[No Abstract] [Full Text] [Related]
5. Automatic external defibrillator, life vest defibrillator, or both?
Richard Conti C
Clin Cardiol; 2010 Dec; 33(12):722-3. PubMed ID: 21184554
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
7. Wearable Cardioverter Defibrillator "The Lifevest": Device Design, Limitations, and Areas of Improvement.
Agarwal M; Narcisse D; Khouzam N; Khouzam RN
Curr Probl Cardiol; 2018 Feb; 43(2):45-55. PubMed ID: 29277221
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
[TBL] [Abstract][Full Text] [Related]
9. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
[TBL] [Abstract][Full Text] [Related]
10. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
11. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695
[No Abstract] [Full Text] [Related]
12. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
Weinstock J
Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
[TBL] [Abstract][Full Text] [Related]
14. The role of the wearable cardioverter defibrillator in clinical practice.
Chung MK
Cardiol Clin; 2014 May; 32(2):253-70. PubMed ID: 24793801
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
[TBL] [Abstract][Full Text] [Related]
16. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis.
Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo-Tcheugui JB; Martin DT; Joseph J; Singh JP
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009139. PubMed ID: 33554611
[TBL] [Abstract][Full Text] [Related]
17. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database.
Hummel JP; Leipold RJ; Amorosi SL; Bao H; Deger KA; Jones PW; Kansal AR; Ott LS; Stern S; Stein K; Curtis JP; Akar JG
J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1066-1077. PubMed ID: 30938894
[TBL] [Abstract][Full Text] [Related]
19. Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses.
Olgin JE; Lee BK; Vittinghoff E; Morin DP; Zweibel S; Rashba E; Chung EH; Borggrefe M; Hulley S; Lin F; Hue TF; Pletcher MJ
J Cardiovasc Electrophysiol; 2020 May; 31(5):1009-1018. PubMed ID: 32083365
[TBL] [Abstract][Full Text] [Related]
20. End-of-life of implantable defibrillator: are we certain it should always be replaced?
Stazi F
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
